🔎 Trials Near Me

መነሻ › ሶፍት ቲሹ ሳርኮማ › Ohio

በOhio ለሶፍት ቲሹ ሳርኮማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሶፍት ቲሹ ሳርኮማ የሚደረጉ 23 ጥናቶች በOhio ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በOhio ውስጥ ያሉ ከተሞች

Official study text (English)

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Cleveland Clinic - Oncology Department, Cleveland
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06760819

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Summa Health System - Akron Campus, Akron
  • Cleveland Clinic Akron General, Akron
  • Summa Health System - Barberton Campus, Barberton
  • እና 44 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

  • Ohio State University Comprehensive Cancer Center, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06528769

DESTINY-PANTUMOUR04

  • Research Site, Canton
  • Research Site, Maumee
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07124000

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Cincinnati Children's Hospital Medical Center, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT03715933

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

  • Nationwide Children's Hospital, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ12 እስከ 40 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07725380

Actinium Therapy for Late-stage Aggressive Sarcomas

  • Case Western, Cleveland
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07156565

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

  • The James Cancer Hospital and Solove Research Institute, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT06263231

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

  • Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05210374

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

  • OSU James Hospital, Columbus
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁላይ 2026 · NCT07377747

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • Ohio State University, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

  • Aultman Alliance Community Hospital, Alliance
  • Aultman Hospital, Canton
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ19 እስከ 110 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT02012699

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • The Ohio State University Wexner Medical Center, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT03093116

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

  • Ohio State University, Columbus
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ፌብሩ 2026 · NCT02677961

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ2 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT05734066

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

  • Ohio State University Comprehensive Cancer Center, Columbus
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ፌብሩ 2026 · NCT06500065

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Cleveland Clinic, Cleveland
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጃንዩ 2026 · NCT05366881

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ዲሴም 2025 · NCT06943521

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • Cincinnati Children's Hospital Medical Center, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 15 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2025 · NCT06298916

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Nationwide Children's Hospital, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 2
18 Months – 40 Years · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2025 · NCT05135975

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

  • Cleveland Clinic, Cleveland
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኖቬም 2024 · NCT05824975

REtroperitoneal SArcoma Registry: an International Prospective Initiative

  • The Ohio State University, Columbus
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ፌብሩ 2019 · NCT03838718

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።